|
1
|
Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus?
|
J Matern Fetal Neonatal Med
|
2012
|
1.43
|
|
2
|
Use of buprenorphine in pregnancy: patient management and effects on the neonate.
|
Drug Alcohol Depend
|
2003
|
1.36
|
|
3
|
Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure.
|
Drug Alcohol Depend
|
2004
|
1.26
|
|
4
|
Mood disorders affect drug treatment success of drug-dependent pregnant women.
|
J Subst Abuse Treat
|
2006
|
1.22
|
|
5
|
A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes.
|
Subst Abuse
|
2013
|
1.16
|
|
6
|
Response to Wouldes and Woodward: maternal methadone dose during pregnancy and infant clinical outcome.
|
Neurotoxicol Teratol
|
2013
|
1.15
|
|
7
|
Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data.
|
Am J Addict
|
2013
|
1.10
|
|
8
|
A partner's drug-using status impacts women's drug treatment outcome.
|
Drug Alcohol Depend
|
2003
|
1.08
|
|
9
|
The impact of managed care on drug-dependent pregnant and postpartum women and their children.
|
Subst Use Misuse
|
2007
|
1.07
|
|
10
|
Drug use and HIV risk outcomes in opioid-injecting men in the Republic of Georgia: behavioral treatment + naltrexone compared to usual care.
|
Drug Alcohol Depend
|
2011
|
1.02
|
|
11
|
Comparing homeless and domiciled pregnant substance dependent women on psychosocial characteristics and treatment outcomes.
|
Drug Alcohol Depend
|
2003
|
0.98
|
|
12
|
Cigarette smoking knowledge, attitudes, and practices of patients and staff at a perinatal substance abuse treatment center.
|
J Subst Abuse Treat
|
2010
|
0.98
|
|
13
|
Double jeopardy--drug and sex risks among Russian women who inject drugs: initial feasibility and efficacy results of a small randomized controlled trial.
|
Subst Abuse Treat Prev Policy
|
2012
|
0.97
|
|
14
|
Lessons learned from a randomized trial of fixed and escalating contingency management schedules in opioid-dependent pregnant women.
|
Am J Drug Alcohol Abuse
|
2012
|
0.97
|
|
15
|
Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication.
|
Addiction
|
2012
|
0.96
|
|
16
|
Co-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant women.
|
Am J Addict
|
2010
|
0.95
|
|
17
|
Fetal neurobehavioral effects of exposure to methadone or buprenorphine.
|
Neurotoxicol Teratol
|
2010
|
0.94
|
|
18
|
Twice stigmatized: provider's perspectives on drug-using women in the Republic of Georgia.
|
J Psychoactive Drugs
|
2013
|
0.94
|
|
19
|
The impact of mood disorders on the delivery and neonatal outcomes of methadone-maintained pregnant patients.
|
Am J Drug Alcohol Abuse
|
2009
|
0.93
|
|
20
|
Psychopharmacologic management of opioid-dependent women during pregnancy.
|
Am J Addict
|
2009
|
0.92
|
|
21
|
Determination of methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine, 2-ethyl-5-methyl-3,3-diphenylpyraline and methadol in meconium by liquid chromatography atmospheric pressure chemical ionization tandem mass spectrometry.
|
J Chromatogr B Analyt Technol Biomed Life Sci
|
2005
|
0.92
|
|
22
|
Partner violence impacts the psychosocial and psychiatric status of pregnant, drug-dependent women.
|
Addict Behav
|
2004
|
0.91
|
|
23
|
Relationship between cigarette use and mood/anxiety disorders among pregnant methadone-maintained patients.
|
Am J Addict
|
2009
|
0.91
|
|
24
|
Neonatal neurobehavior effects following buprenorphine versus methadone exposure.
|
Addiction
|
2012
|
0.88
|
|
25
|
Behavioral treatment + naltrexone reduces drug use and legal problems in the Republic of Georgia.
|
Am J Drug Alcohol Abuse
|
2012
|
0.87
|
|
26
|
Fetal assessment before and after dosing with buprenorphine or methadone.
|
Addiction
|
2012
|
0.87
|
|
27
|
A comparison of cigarette smoking profiles in opioid-dependent pregnant patients receiving methadone or buprenorphine.
|
Nicotine Tob Res
|
2013
|
0.85
|
|
28
|
Maternal treatment with opioid analgesics and risk for birth defects: additional considerations.
|
Am J Obstet Gynecol
|
2011
|
0.85
|
|
29
|
Post-cesarean pain management of patients maintained on methadone or buprenorphine.
|
Am J Addict
|
2006
|
0.85
|
|
30
|
Buprenorphine and norbuprenorphine in hair of pregnant women and their infants after controlled buprenorphine administration.
|
Clin Chem
|
2007
|
0.85
|
|
31
|
Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates.
|
Addiction
|
2012
|
0.82
|
|
32
|
Abstinence-contingent recovery housing and reinforcement-based treatment following opioid detoxification.
|
Addiction
|
2012
|
0.81
|
|
33
|
Effect of hepatitis C virus status on liver enzymes in opioid-dependent pregnant women maintained on opioid-agonist medication.
|
Addiction
|
2012
|
0.81
|
|
34
|
Usefulness of salivary trans-3'-hydroxycotinine concentration and trans-3'-hydroxycotinine/cotinine ratio as biomarkers of cigarette smoke in pregnant women.
|
J Anal Toxicol
|
2005
|
0.80
|
|
35
|
Methadone and metabolites in hair of methadone-assisted pregnant women and their infants.
|
Ther Drug Monit
|
2012
|
0.80
|
|
36
|
The efficacy of escalating and fixed contingency management reinforcement on illicit drug use in opioid-dependent pregnant women.
|
Addict Disord Their Treat
|
2012
|
0.79
|
|
37
|
The complexity of examining developmental outcomes of children prenatally exposed to opiates. A response to the Hunt et al. Adverse neurodevelopmental outcome of infants exposed to opiates in-utero. Early Human Development (2008, 84, 29-35).
|
Early Hum Dev
|
2008
|
0.79
|
|
38
|
Female partners of opioid-injecting men in the Republic of Georgia: an initial characterization.
|
Subst Abuse Treat Prev Policy
|
2012
|
0.78
|
|
39
|
Opioid dependence during pregnancy: relationships of anxiety and depression symptoms to treatment outcomes.
|
Addiction
|
2012
|
0.78
|
|
40
|
The relationship between antidepressant use and smoking cessation in pregnant women in treatment for substance abuse.
|
Am J Drug Alcohol Abuse
|
2010
|
0.78
|
|
41
|
Excretion of methadone in sweat of pregnant women throughout gestation after controlled methadone administration.
|
Ther Drug Monit
|
2010
|
0.78
|
|
42
|
Screening for Mood Disorder in Pregnant Substance-dependent Patients.
|
Addict Disord Their Treat
|
2009
|
0.77
|
|
43
|
Infections and obstetric outcomes in opioid-dependent pregnant women maintained on methadone or buprenorphine.
|
Addiction
|
2012
|
0.77
|
|
44
|
Methadone and the causes of maternal and perinatal complications: a response to Pinto et al. "Substance abuse during pregnancy: effect on pregnancy outcomes" [Eur. J. Obstet. Gynecol. Reprod. Biol. 150 (2010) 137-141].
|
Eur J Obstet Gynecol Reprod Biol
|
2011
|
0.77
|
|
45
|
Methadone and perinatal outcomes: another perspective.
|
Am J Obstet Gynecol
|
2011
|
0.76
|
|
46
|
Comments on: Efficacy versus effectiveness of buprenorphine and methadone maintenance in pregnancy.
|
J Addict Dis
|
2012
|
0.75
|
|
47
|
Cigarette Smoking and Neonatal Outcomes in Depressed and Non-Depressed Opioid-Dependent Agonist-Maintained Pregnant Patients.
|
Addict Disord Their Treat
|
2011
|
0.75
|
|
48
|
Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance.
|
J Addict Med
|
2017
|
0.75
|